| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AGLE | Aeglea BioTherapeutics, Inc. | Alspaugh Jonathan | Chief Financial Officer | Mar 11, 2022 | Buy | $2.08 | 75,000 | 156,000 | 165,372 | Mar 15, 2022, 06:30 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Alspaugh Jonathan | Chief Financial Officer | Dec 09, 2021 | Buy | $3.72 | 50,000 | 186,000 | 90,372 | Dec 13, 2021, 08:37 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Alspaugh Jonathan | Chief Financial Officer | Aug 16, 2021 | Buy | $6.37 | 9,780 | 62,275 | 9,780 | Aug 18, 2021, 05:21 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Alspaugh Jonathan | Chief Financial Officer | Aug 17, 2021 | Buy | $6.50 | 23,392 | 151,985 | 33,172 | Aug 18, 2021, 05:21 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Alspaugh Jonathan | Chief Financial Officer | Aug 18, 2021 | Buy | $6.72 | 7,200 | 48,400 | 40,372 | Aug 18, 2021, 05:21 PM |
Menu